Literature DB >> 28735836

Importance of deformable image registration and biological dose summation in planning of radiotherapy retreatments.

Eeva Boman1, Mika Kapanen2, Lyndsey Pickup3, Sirpa-Liisa Lahtela4.   

Abstract

The purpose of this study is to evaluate the effect of nonrigid and fractionation-corrected dose summation on total doses in radiotherapy and to demonstrate the benefits of such dose summation on clinical decision-making for planning of retreatments. Dose summation of organs at risk (OARs) was investigated for 3 clinical cases with need of retreatment to the same site: head and neck, brain, and mediastinum. Three different summation methods over old and new radiotherapy treatment plans are presented and compared: (1) rigid raw sum with rigid registration of the planning images and direct dose summing; (2) deformable raw sum with deformable image registration and direct dose summing; and (3) deformable biological sum with deformable registration and takes into account the dose per fraction in biological manner in certain critical organs. In 2 cases, a user-defined dose downscaling is applied to take into account the time between the treatments and the healing from the radiation-induced effects. Of the 3 summation methods presented, the deformable biological sum was considered to offer the most biologically plausible account of the treatment. There were remarkable differences between near-maximum doses (D0.1cc) and dose-volume histogram (DVH) curves for OARs between different summation methods. The differences between deformable raw sum and rigid raw sum D0.1cc doses are in the range from -8 Gy to 2 Gy. Similarly, the deviation was from -14 Gy to 5 Gy for the deformable biological sum compared with the rigid raw sum. These differences come from incorrect summation of doses in the rigid raw sum case, and from the dose per fraction effect in biological summation. We conclude that computing the 3-dimensional deformable biological summation could be a valuable tool for treating patients with complex retreatments. It has the potential to assist the oncologist in refining plans for maximally curative doses while respecting appropriate tissue tolerances.
Copyright © 2017 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biological dose; Deformable registration; Dose summation; Treatment planning

Mesh:

Year:  2017        PMID: 28735836     DOI: 10.1016/j.meddos.2017.06.006

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  4 in total

Review 1.  Adaptive proton therapy.

Authors:  Harald Paganetti; Pablo Botas; Gregory C Sharp; Brian Winey
Journal:  Phys Med Biol       Date:  2021-11-15       Impact factor: 3.609

2.  Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases.

Authors:  Taoran Cui; Joseph Weiner; Shabbar Danish; Anupama Chundury; Nisha Ohri; Ning Yue; Xiao Wang; Ke Nie
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

3.  Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study.

Authors:  Esther G C Troost; Krista C J Wink; Erik Roelofs; Charles B Simone; Sebastian Makocki; Steffen Löck; Peter van Kollenburg; David Dechambre; Andre W H Minken; Judith van der Stoep; Stephen Avery; Nicolas Jansen; Timothy Solberg; Johan Bussink; Dirk de Ruysscher
Journal:  Br J Radiol       Date:  2019-12-20       Impact factor: 3.039

4.  Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives.

Authors:  Nevin McVicar; Steven Thomas; Mitchell Liu; Hannah Carolan; Alanah Bergman
Journal:  J Appl Clin Med Phys       Date:  2018-10-29       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.